Data has shown that a mono-allelic loss of GRIM-19 can promote carcinogenesis in mice [11] and the tumor-derived mutations in GRIM-19 in human can also promote tumor growth in mice [12]. The gene discussed is NDUFA13; the disease is neoplasm.